535 results on '"Zoeller, R. Thomas"'
Search Results
2. Letter to the editor regarding Hall et al. (2023): Fluoride exposure and hypothyroidism in a Canadian pregnancy cohort
3. Neuroendocrine effects of polychlorinated biphenyls (PCBs)
4. Fluoride exposure and hypothyroidism in a Canadian pregnancy cohort
5. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification
6. The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA)
7. Comparative Analyses of the 12 Most Abundant PCB Congeners Detected in Human Maternal Serum for Activity at the Thyroid Hormone Receptor and Ryanodine Receptor
8. Polybrominated diphenyl ethers (PBDEs) and hydroxylated PBDE metabolites (OH-PBDEs) in maternal and fetal tissues, and associations with fetal cytochrome P450 gene expression
9. Correction to: Parma consensus statement on metabolic disruptors.
10. Data integration, analysis, and interpretation of eight academic CLARITY-BPA studies
11. Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement
12. European Medicines Agency Conflicts With the European Food Safety Authority (EFSA) on Bisphenol A Regulation
13. Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012".
14. Parma consensus statement on metabolic disruptors
15. Endocrine disrupting chemicals and thyroid hormone action
16. Endocrine-Disrupting Chemicals: Brain–Behavior Effects on Thyroid and Sexual Differentiation
17. Temporal Comparison of PBDEs, OH-PBDEs, PCBs, and OH-PCBs in the Serum of Second Trimester Pregnant Women Recruited from San Francisco General Hospital, California
18. The Impact of Endocrine Disruption: A Consensus Statement on the State of the Science
19. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society.
20. Upstream adverse effects in risk assessment: A model of polychlorinated biphenyls, thyroid hormone disruption and neurological outcomes in humans
21. Polychlorinated Biphenyls 105 and 118 Form Thyroid Hormone Receptor Agonists after Cytochrome P4501A1 Activation in Rat Pituitary GH3 Cells
22. Evaluation of the U.S. EPA/OSWER Preliminary Remediation Goal for Perchlorate in Groundwater: Focus on Exposure to Nursing Infants
23. Adverse effects in risk assessment: Modeling polychlorinated biphenyls and thyroid hormone disruption outcomes in animals and humans
24. Polychlorinated Biphenyls (PCBs) Exert Thyroid Hormone-like Effects in the Fetal Rat Brain but Do Not Bind to Thyroid Hormone Receptors
25. Effects of Sample Handling and Analytical Procedures on Thyroid Hormone Concentrations in Pregnant Women’s Plasma
26. Meeting Report: Moving Upstream—Evaluating Adverse Upstream End Points for Improved Risk Assessment and Decision-Making
27. Thyroid Hormone, Brain Development, and the Environment
28. Impacts of food contact chemicals on human health: a consensus statement
29. Application of In Situ Hybridization to the Study of Rhythmic Neural Systems
30. A vision for safer food contact materials: public health concerns as drivers for improved testing
31. Evaluating the Effects of Endocrine Disruptors on Endocrine Function during Development
32. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis
33. Maternal thyroid function during pregnancy or neonatal thyroid function and attention deficit hyperactivity disorder: A systematic review
34. Gestational thyroid hormone concentrations and risk of attention‐deficit hyperactivity disorder in the Norwegian Mother, Father and Child Cohort Study
35. NIEHS/FDA CLARITY-BPA research program update
36. Urinary concentrations of phthalate biomarkers and weight change among postmenopausal women: a prospective cohort study
37. Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement
38. 137 - Endocrine-Disrupting Chemicals and Human Health
39. Endocrine Disruption of the Thyroid and its Consequences in Development
40. Gestational thyroid hormone concentrations and risk of attention‐deficit hyperactivity disorder in the Norwegian Mother, Father and Child Cohort Study.
41. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology
42. Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: A dynamic and kinetic evaluation of a putative mode-of-action
43. Toward the Production of Safer Chemicals: A new protocol for safer chemical design is helping to overcome gaps in 'traditional' toxicology and improve upon federal regulations for endocrine-disrupting chemicals.
44. Endocrine-Disrupting Chemicals and Human Disease∗
45. Contributors
46. A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health
47. Thyroid-Disrupting Chemicals: Interpreting Upstream Biomarkers of Adverse Outcomes
48. Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A
49. The Price We Pay for the Convenience of Plastics.
50. Endocrine-Disrupting Activity of Hydraulic Fracturing Chemicals and Adverse Health Outcomes After Prenatal Exposure in Male Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.